Status:
COMPLETED
Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy
Lead Sponsor:
State University of New York at Buffalo
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
25-90 years
Phase:
PHASE3
Brief Summary
Hysterectomy is the most common major gynecologic surgery performed in the US and is performed for a variety of indications including malignancy, pelvic mass, endometriosis, leiomyoma, and pelvic orga...
Detailed Description
Material and Methods: This is a prospective cohort study with historical controls. Cases of those receiving a non-opioid multimodal pain regimen will be compared to historical controls of those recei...
Eligibility Criteria
Inclusion
- Women undergoing robotic-assisted total laparoscopic hysterectomy, with or without bilateral salpingo-oophorectomy
- Uterine weight ≤325 grams
Exclusion
- contraindication to any study medications (h/o gastric bypass, gastric ulcers, CKD)
- current opioid prescription
Key Trial Info
Start Date :
November 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04429022
Start Date
November 24 2020
End Date
May 31 2022
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Millard Fillmore Suburban Hospital
Williamsville, New York, United States, 14221